PetVivo Holdings, Inc. (PETV)

0.5410 -0.0190 (-3.39%) At close: 04:00PM EDT

PetVivo Holdings, Inc.

5151 Edina Industrial Boulevard
Suite 575
Edina, MN 55439
United States
(952) 405-6216
https://www.petvivo.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 20

Key executives

Name	Title	Pay	Exercised	Year born
Mr. John Lai	CEO, President & Director	353.91k	N/A	1962
Mr. Garry N. Lowenthal	Chief Financial Officer	32.78k	N/A	1959
Mr. Randall A. Meyer	Chief Operating Officer	282.91k	N/A	1964
Mr. Randy Wenthold	Chief Science Officer	N/A	N/A	N/A
Mr. John F. Dolan	General Counsel, Chief Business Development Officer & Secretary	40.25k	N/A	1965
Mr. Gary DeMel	Executive Vice President of Business Development	N/A	N/A	1957
Ms. April Boyce	Vice President of Marketing	N/A	N/A	N/A
Mr. Bryan Monninger	Vice President of Sales	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Corporate governance

PetVivo Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.